secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2023-04-04T23:59:59+00:00
Accession:  0001000694-23-000011
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novavax amends bylaws to align with Delaware law on meeting adjournment and stockholder list
--------------------------------------------------------------------------------

- Board adopted Amended and Restated By-Laws effective March 30, 2023.
- Changes reflect 2022 DGCL amendments: allow adjournment as permitted, remove stockholder list requirement at meetings.
- Stock certificates may now be signed by any two authorized officers instead of specific officers.
- Amendments are procedural; no immediate financial or operational impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000100069423000011/0001000694-23-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000100069423000011/nvax-20230330.htm
  HTML page:      https://secwatch.observer/filing/0001000694-23-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer